Use of a clostridial toxin to reduce appetite

Details for Australian Patent Application No. 2004251708 (hide)

Owner Allergan, Inc.

Inventors Voet, Martin A.

Agent Davies Collison Cave

Pub. Number AU-A-2004251708

PCT Pub. Number WO2005/000343

Priority 10/459,767 11.06.03 US

Filing date 7 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000343 Priority application(s): WO2005/000343

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251710-Compositions and methods for treatment of rosacea

2004251705-Stable cosmetic emulsion with polyamide